Jump to content
The World News Media

PCSK9 inhibitors benefit patients with residual LDL burden - Healio


Health and Medicine

Recommended Posts

  • Administrator
images?q=tbn:ANd9GcSja5dvjgAEgd1Tl8tH1fA
New York Times

PCSK9 inhibitors benefit patients with residual LDL burden
Healio
NEW ORLEANS — A leading authority on PCSK9 inhibitors told the audience at the National Lipid Association Scientific Sessions that while the drugs can lower LDL by large amounts, use of PCSK9 inhibitors should be restricted to those with excessive LDL ...
Well | Ask Well: Should You Fast Before a Cholesterol Test?New York Times (blog)
Treating lifelong high cholesterol levels is challengeKilgore News Herald
New Cholesterol Treatment Now Available for CanadiansOttawa Citizen
Online Athens -Montreal Gazette
all 6 news articles »

Google

Link to comment
Share on other sites


  • Views 243
  • Replies 0
  • Created
  • Last Reply

Top Posters In This Topic

Popular Days

Top Posters In This Topic

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...




×
×
  • Create New...

Important Information

Terms of Service Confirmation Terms of Use Privacy Policy Guidelines We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.